Abstract
Multiple endocrine neoplasia type 2 (MEN2) is a rare autosomal dominant disorder that predisposes patients to medullary thyroid cancer (MTC), pheochromocytoma (PHEO), and primary parathyroid hyperplasia (PHPT). MEN2 is subclassified into three distinct syndromes: Multiple endocrine neoplasia type 2A (MEN2A), multiple endocrine neoplasia type 2B (MEN2B), and familial medullary thyroid cancer (FMTC). All three syndromes are the result of mutations of the RET proto-oncogene. The diagnosis and management of MEN2 syndromes in children is discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
